Sonoma Pharmaceuticals Inc (SNOA)
US$ 3.9569.53%
Price Chart
Key Statistics
Market Cap
$ 6.24M
P/E Ratio
0.00
Revenue (TTM)
$ 13.97M
Volume
27.11M
52W High
$ 9.37
52W Low
$ 1.75
Dividend Yield
0.00%
Beta
1.68
Technicals
50-Day MA
2.6282
200-Day MA
3.4076
52 Week High
9.374
52 Week Low
1.75
About SNOA
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye and nasal care, oral care, and dermatological conditions in the.
Employees
10
Headquarters
Boulder, CO
CEO
Ms. Amy M. Trombly J.D.
Latest News
Sonoma Pharmaceuticals (SNOA) Expands Acne Product Line to UK Re - GuruFocus
2 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg